Newsroom

For media enquiries or more information about Communications at the 
Djavad Mowafaghian Centre for Brain Health, please contact:

Emily Wight, Communications Manager
Email: emily.wight@brain.ubc.ca | Phone: 604.827.3396

THC makes rats lazy, less willing to try cognitively demanding tasks Aug 23, 2016

New research from Dr. Catharine Winstanley's lab, published today in the Journal of Psychiatry and Neuroscience, suggests there may be some truth to the belief that marijuana use causes laziness—at least in rats. 

The researchers discovered that tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana, makes rats less willing to try a cognitively demanding task.

+
Dr. Brian MacVicar in his lab
Centre members receive CIHR funding to further brain health research Aug 5, 2016

The Canadian Institutes for Health Research (CIHR) has announced its latest grants, and 14 members of the Djavad Mowafaghian Centre for Brain Health are among the awardees.

Brian MacVicar, Professor, Department of Psychiatry and Co-Director of the Centre received the largest grant in the Faculty of Medicine from CIHR’s latest round of awards, with a Foundation Grant of $3.3 million over seven years. Dr. MacVicar’s lab will explore neuron-glia interactions in brain disease.

+
CARD 2016 Alzheimer Update participant with iClicker
Patient collaboration in research leads to meaningful outcomes Jul 8, 2016

Dr. Julie Robillard believes that good research puts patients first. In the labs and clinics of the Djavad Mowafaghian Centre for Brain Health, she has been working hard to improve communication between researchers and the people who could most benefit from their work and to integrate patients into research from the beginning, at every stage from study design to communication of results.

+
Pharmacists
Researchers tackle non-adherence to MS medication in new study Jul 6, 2016

For some patients with multiple sclerosis (MS), adhering to a strict disease-modifying therapy (DMT) regimen can be challenging. Some DMTs for the treatment of relapsing-remitting MS are injectable and require long-term use, so it’s understandable that some patients may not adhere well to these treatments. Kyla McKay, PhD candidate and epidemiology researcher with Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group, set out to discover why.

+
Dr. Max Cynader appointed to CIHR College of Reviewers Jun 17, 2016

Dr. Max Cynader has been appointed to a Chair in the Canadian Institutes for Health Research (CIHR) College of Reviewers, a new program that will serve CIHR and its stakeholders by bringing together a diverse cohort of researchers to enhance the quality of the peer review process.

+
CERC Spotlight on Dr. Matthew Farrer Jun 16, 2016

When he joined The University of British Columbia (UBC) in 2010 as Canada Excellence Research Chair (CERC) in Neurogenetics and Translational Neuroscience, Dr. Matthew Farrer arrived with the reputation of having made some of the most significant contributions to Parkinson’s disease research over the previous decade.

+
Eric Marcotte and Ravi Rungta at CAN 2016
Ravi Rungta receives Marlene Reimer Brain Star of the Year award Jun 10, 2016

Former MacVicar lab post-doctoral student Dr. Ravi Rungta (pictured right, with Dr. Eric Marcotte) is one of 15 recipients of a Canadian Institutes of Health Research (CIHR) 2015 Brain Star Award.  

As one of the top three, he was funded to attend the Canadian Association for Neuroscience Meeting in Toronto in May, where he presented his research which focuses on understanding the process by which neurons die after trauma from stroke, brain injury, hypoxia and infections

+
Carles Vilarino-Guell
Researchers find genetic cause of multiple sclerosis Jun 1, 2016

The mutation was found in two Canadian families that had several members diagnosed with a rapidly progressive type of MS, in which a person’s symptoms steadily worsen and for which there is no effective treatment.

+
Older man thinking
Newly discovered biomarker offers genetic predictor of dementia in Parkinson disease May 24, 2016

For patients with Parkinson disease (PD), cognitive decline can be one of the most debilitating symptoms of the condition. As many as 80 per cent of people with PD experience some form of cognitive impairment, with up to a quarter of patients presenting symptoms of memory loss or impairment at diagnosis.

+

Pages